econtinence.app

What It Is

Tät® is a mobile health app launched by Sweden’s eContinence AB. Its core goal is to help users with self-management of urinary incontinence and pelvic floor muscle training. The company was founded by physicians and researchers involved in the Umeå University Tät.nu research project, and the product is positioned more like an evidence-based digital therapy/medical health tool than a typical AI tool.

Core Capabilities

According to the main content, Tät® provides information on the pelvic floor, stress urinary incontinence, lifestyle-related factors, and more. It also includes a pelvic floor muscle training program designed to help users stick with training that can be relatively challenging. Its clinical evidence is a major strength: randomized controlled trials show that after three months of continuous use by women, symptoms, quality of life, and leakage frequency improved compared with the control group; two-year follow-up showed that these improvements could be maintained. In real-world cohorts, about two-thirds of users who completed follow-up questionnaires reported improvement; in preventive training during pregnancy, around 72% maintained urinary control, while about 73% of postpartum users with urinary incontinence improved. Multiple systematic reviews have also identified it as a relatively high-quality app with a foundation in clinical evaluation.

AI, Pricing, and Integrations

It should be noted that the collected content does not mention AI, machine learning, large language models, intelligent consultation, or personalized algorithms, so it should not be classified as a product with clearly defined AI capabilities. In terms of pricing, it only mentions that a free version and a Premium version were released in 2022, without disclosing prices, subscription periods, or differences in benefits. Information on APIs and integrations is also limited: it only mentions collaboration with Evidensa AB and the “One million babies” app, without technical details.

Pros and Cons

Its advantages are strong medical evidence, development by a professional medical team, CE Class I medical device marking under MDR 2017/745, and recommendations by relevant Swedish institutions and healthcare settings. Its drawbacks are that effectiveness depends heavily on regular training and sustained use; real-world outcomes are weaker than those in controlled studies; and the main content does not explain its privacy policy, Chinese-language support, payment methods, or accessibility in China.

Who It’s For and Access in China

It is suitable for women with stress urinary incontinence, pregnancy-related prevention needs, postpartum recovery needs, and pelvic floor muscle training needs. It also extends to a male training version, Tät®-m. If users are looking for AI diagnosis or an intelligent health assistant, it is not a good match. Access, download availability, and localization support in mainland China are not disclosed in the main content, so they should be considered unknown.